Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
Syndax Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Syndax Pharmaceuticals reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, three executives at Syndax Pharmaceuticals received on average a compensation package of $1.6M, a 21% increase compared to previous year.
Average pay of disclosed executives at Syndax Pharmaceuticals
Briggs W. Morrison, Chief Executive Officer, received $2.1M in total, which increased by 24% compared to 2017. 61% of Morrison's compensation, or $1.3M, was in option awards. Morrison also received $248K in non-equity incentive plan, $566K in salary, as well as $3K in other compensation.
Michael A. Metzger, Chief Operating Officer, received a compensation package of $1.5M, which increased by 24% compared to previous year. 52% of the compensation package, or $791K, was in option awards.
Michael L. Meyers, Chief Medical Officer, earned $1.1M in 2018, a 13% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2019.